DIG
INMB icon

Dauntless Investment Group’s INmune Bio INMB Stock Holding History

Dauntless Investment Group’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163 Sell
100
-183,376
-100% -$254K ﹤0.01% 68
2026
Q1 		$207K Sell
183,476
-121,446
-40% -$173K 0.14% 45
2025
Q4 		$476K Buy
+304,922
New +$544K 0.38% 35
2025
Q3 		– Sell
-248,542
Closed -$311K – 87
2025
Q2 		$311K Buy
248,542
+117,862
+90% +$865K 0.54% 31
2025
Q1 		$1.02M Sell
130,680
-61,142
-32% -$486K 1.19% 16
2024
Q4 		$896K Buy
+191,822
New +$1M 0.94% 15

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dauntless Investment Group's INMB Position: Q2 2026 in Review

Dauntless Investment Group reduced its INmune Bio (INMB) stake by 100% in Q2 2026, selling an estimated $254K and leaving 100 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #68.

Dauntless Investment Group first reported a position in INMB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q1 2025. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Dauntless Investment Group held 100 shares of INmune Bio worth $163 as of Q2 2026.
  • Dauntless Investment Group sold 183,376 INmune Bio shares in Q2 2026, an estimated $254K.
  • INmune Bio made up ﹤0.01% of Dauntless Investment Group's portfolio in Q2 2026, its #68 holding.
  • Dauntless Investment Group first reported a position in INmune Bio in Q4 2024 and has held it in 6 quarters since.
  • Dauntless Investment Group's INmune Bio position peaked at $1.02M in Q1 2025.
  • 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.